Tuesday, November 28, 2023
Mitochondrial Health

Predicting Patient Outcomes from Single Cells in Childhood Cancer

Acute lymphoblastic leukemia (ALL) is the most common cancer of childhood and one of the deadliest despite impressive improvements in survival. The Davis lab uses single-cell, high-dimensional analysis to identify the most important cells, those that are resistant to standard and cutting-edge therapies, leading to relapse. By identifying and understanding these treatment resistant cells can we work to prevent relapse and cure more children and young adults with ALL.
A Continuing Medical Education activity presented by the Stanford University School of Medicine. View CE information and claim credit at https://stanford.cloud-cme.com/course/courseoverview?P=0&EID=42951


Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *